Preview Mode Links will not work in preview mode
Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape.  Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes  Value-based healthcare  Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials  Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Oct 31, 2024

Dr. Sam Lee, Co-CEO of Cocrystal Pharma, is an expert in developing small-molecule antiviral drugs to treat COVID-19, Norovirus, influenza, avian flu, West Nile virus, Dengue, Zika, and other RNA viruses. Cocrystal uses its structure-based drug discovery platform to identify promising drug targets for potent broad-spectrum oral and inhaled antiviral therapeutics. The COVID-19 pandemic highlighted the need for vaccines and effective therapeutics to respond to viral outbreaks and prevent further transmission.

Sam elaborates, "Before we talk about avian flu, let's just step back up about the strains. Influenza, as you know, includes influenza A strains, influenza B, and the C. But the public health point of view is the influenza A strains are important. These cause the pandemic flu, as well as the seasonal flu. Influenza B is roughly less than 20% of flu patients that have this influenza B. It's seasonal. It doesn't cause a pandemic influenza infection."

"So we're talking about avian flu. Avian flu is mostly an influenza A strain. So, it's often classified as H5N1 or H7N9, depending on the antigen. So, why is it so important? We know this year that people isolate the avian H5N1 from cow and cow milk and humans. Avian flu is normally avian influenza that stays with the birds, the wild birds. What we see here is already past the host barrier. So instead of staying with avian, the birds, or domestic animals, now it's passed to a human. So it's a serious issue that the avian flu, H5N1, actually we see here, not only cow and farm workers are infected with it. That's a really serious concern."

"We believe we have a pretty good understanding. If you look at the 1918 Spanish flu, that was actually classified as an H1N1, but several years ago, with a beautiful molecular analysis, people completed the sequencing analysis with the patient sample from 1918 Spanish flu victims. They isolated the gene. They showed that even those with H1N1 contained the avian flu sequence."

#CocrystalPharma #AvianFlu #Influenza #WestNileVirus #AntiviralTherapeutics #RNAViruses #COVID19

CocrystalPharma.com

Download the transcript here

Cocrystal Pharma